Superworth

Agenus market cap AGEN

Share price times shares outstanding: what the whole company sells for, since 2011.

Today, Nov 2, 2026
$294M
Highest close in our data
$1.5B
Sep 2021

Agenus is worth $294M at the close on Nov 2, 2026, at $6.53 a share.

That is up 132% over the last year and down 70% over five years.

Its highest close in our data was $1.5B in Sep 2021.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$294M$96.6M$384.5M+161%
2025$112.6M$39.5M$193.6M+74%
2024$64.5M$63.8M$351.7M−80%
2023$315.9M$248M$899.2M−57%
2022$731.5M$395.6M$932.7M−12%
2021$827M$536.3M$1.5B+37%
2020$604.7M$310.3M$950.2M+6%
2019$568.7M$316.9M$575.5M+98%
2018$286.8M$181M$585.1M−12%
2017$326.6M$326.6M$500.6M−9%
2016$359M$239.5M$624.7M−7%
2015$384.3M$249.5M$677.7M+48%
2014$258.9M$99.3M$268.6M+173%
2013$94.7M$71.7M$124.3M+4%
2012$91.5M$51.9M$150M+113%
2011$42.9M$42.9M$67.4Mn/a

Against its peers

Companies in Biotechnology nearest Agenus' size, closest first, today.

CompanyMarket cap
AGENAgenus$294M
PLXProtalix BioTherapeutics$206.3M
MGTXMeiraGTx$895.1M
VCELVericel$2.1B
ADMAAdma Biologics$2.5B
Peer median$1.5B

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Agenus

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.